Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03620188 · ClinicalTrials.gov registry record
Treatment Goals in Psoriatic Arthritis
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 250
- Enrollment target
NCT03620188: Completed study, sponsored by Johns Hopkins University.
NCT03620188 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03620188 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.
Interventions
- OTHER Standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03620188
The ClinicalTrials.gov registry entry for NCT03620188 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Standard of care is the first listed.
NCT03620188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03620188 about?
NCT03620188 is a clinical study titled "Treatment Goals in Psoriatic Arthritis". The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.
What is the current status of trial NCT03620188?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2018-12-20. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03620188?
The interventions under investigation include: Standard of care (OTHER).
Who is sponsoring clinical trial NCT03620188?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.